tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENLV Stock Latest News

Enlivex Announces Fireside Chat on RAIN Token and Allocetra Development
Company AnnouncementsEnlivex Announces Fireside Chat on RAIN Token and Allocetra Development
9d ago
6K
ENLV
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy
PremiumCompany Announcements
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy
17d ago
6K
ENLV
Enlivex Therapeutics closes $212M private placement
PremiumThe Fly
Enlivex Therapeutics closes $212M private placement
17d ago
ENLV
3 Penny Stocks to Watch Now, 11/25/25
PremiumMarket News
3 Penny Stocks to Watch Now, 11/25/25
18d ago
AEHL
ENLV
Crypto Currents: Upbit plans IPO, Revolut hits $75B valuation
PremiumThe Fly
Crypto Currents: Upbit plans IPO, Revolut hits $75B valuation
19d ago
C
C
Enlivex Reports Positive Six-Month Data for Knee Osteoarthritis Trial
PremiumCompany AnnouncementsEnlivex Reports Positive Six-Month Data for Knee Osteoarthritis Trial
19d ago
6K
ENLV
Enlivex Completes Private Placement to Fund Digital Asset Strategy
Premium
Company Announcements
Enlivex Completes Private Placement to Fund Digital Asset Strategy
19d ago
6K
ENLV
Enlivex Therapeutics downgraded to Hold from Buy at D. Boral Capital
Premium
The Fly
Enlivex Therapeutics downgraded to Hold from Buy at D. Boral Capital
19d ago
ENLV
Enlivex Therapeutics prices 212M shares at $1.00 in private placement
PremiumThe Fly
Enlivex Therapeutics prices 212M shares at $1.00 in private placement
19d ago
ENLV
Enlivex Therapeutics announces topline data from Phase I/II trial of Allocetra
PremiumThe Fly
Enlivex Therapeutics announces topline data from Phase I/II trial of Allocetra
19d ago
ENLV
Enlivex Reports Q3 2025 Financial Results Amidst Operational Challenges
PremiumCompany Announcements
Enlivex Reports Q3 2025 Financial Results Amidst Operational Challenges
28d ago
6K
ENLV
Enlivex Reschedules Annual Meeting Due to Lack of Quorum
PremiumCompany Announcements
Enlivex Reschedules Annual Meeting Due to Lack of Quorum
1M ago
6K
ENLV
Enlivex Therapeutics Advances Psoriatic Arthritis Treatment with Allocetra Study
PremiumCompany AnnouncementsEnlivex Therapeutics Advances Psoriatic Arthritis Treatment with Allocetra Study
2M ago
ENLV
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
2M ago
BMY
NVS
Enlivex Therapeutics Announces Annual General Meeting for November 2025
Premium
Company Announcements
Enlivex Therapeutics Announces Annual General Meeting for November 2025
3M ago
6K
ENLV
Enlivex’s Strategic Advancements and Patent Protection Drive Buy Rating for Osteoarthritis Treatment
PremiumRatings
Enlivex’s Strategic Advancements and Patent Protection Drive Buy Rating for Osteoarthritis Treatment
3M ago
ENLV
Enlivex Announces Positive Phase IIa Results for Allocetra™ in Knee Osteoarthritis
PremiumCompany Announcements
Enlivex Announces Positive Phase IIa Results for Allocetra™ in Knee Osteoarthritis
3M ago
6K
ENLV
Enlivex Therapeutics CEO issues letter to shareholders on Allocetra results
PremiumThe Fly
Enlivex Therapeutics CEO issues letter to shareholders on Allocetra results
3M ago
ENLV
Enlivex Secures Israeli Patent for Osteoarthritis Treatment
PremiumCompany Announcements
Enlivex Secures Israeli Patent for Osteoarthritis Treatment
3M ago
6K
ENLV
Enlivex Therapeutics announces issuance of Israeli patent for Allocetra
PremiumThe FlyEnlivex Therapeutics announces issuance of Israeli patent for Allocetra
3M ago
ENLV
Promising Potential of Enlivex’s Allocetra in Osteoarthritis: Buy Rating with $7 Price Target
Premium
Ratings
Promising Potential of Enlivex’s Allocetra in Osteoarthritis: Buy Rating with $7 Price Target
3M ago
ENLV
Enlivex Reports Financial Results for Mid-2025
Premium
Company Announcements
Enlivex Reports Financial Results for Mid-2025
4M ago
6K
ENLV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >